Head-to-Head in Heart Failure: Comparative Insights on Empagliflozin and Dapagliflozin.

Biomedicines · 2025 · PMC12561480 · PMID 41153706

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significancep = 0.24not close (p > 0.1)

showed a trendno p-value reported

Additionally, empagliflozin showed a trend toward improvement in the 6 min walk distance (6MWD); however, this difference did not reach statistical significance (SMD 0.49; 95% CI, −0.33 to 1.31; p = 0.24; I 2 = 92.6%).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.